Interestingly, losartan markedly increased proximal tubular caveolin 1, suggesting that intrarenal angiotensin II is involved in the negative regulation of caveolin 1 during the development of hypertension and renal injury in SHR [52]. This evidence concerns the gene CAV1 and hypertensive disorder.